Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats (Q46535152)

22 December 2017

title

Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats (English)

1 reference

22 December 2017

0 references

1 reference

1 reference

22 December 2017

author name string

J D Roth

1 reference

22 December 2017

J Wilson

1 reference

22 December 2017

C Lei

1 reference

22 December 2017

J Athanacio

1 reference

22 December 2017

C Mack

1 reference

22 December 2017

N C Kesty

1 reference

22 December 2017

T Coffey

1 reference

22 December 2017

C Weyer

1 reference

22 December 2017

D G Parkes

1 reference

22 December 2017

language of work or name

English

0 references

publication date

17 June 2008

1 reference

22 December 2017

International Journal of Obesity

published in

1 reference

22 December 2017

volume

1 reference

22 December 2017

issue

1 reference

22 December 2017

page(s)

1201-1210

1 reference

22 December 2017

The gut and energy balance: visceral allies in the obesity wars

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Central nervous system control of food intake and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Amylin: a novel action in the brain to reduce body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Meta-analysis: pharmacologic treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Peroxisome proliferator-activated receptor-gamma regulates expression of PDX-1 and NKX6.1 in INS-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Obese patients' perceptions of treatment outcomes and the factors that influence them

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Efficacy of administration of dexfenfluramine and phentermine, alone and in combination, on ingestive behavior and body weight in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRP alpha) in the fasted, anaesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Amylin receptor blockade stimulates food intake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Anorexia following the intrahypothalamic administration of amylin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Amylin increases transport of tyrosine and tryptophan into the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Effects of long-term infusion of anorexic concentrations of islet amyloid polypeptide on neurotransmitters and neuropeptides in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Anorectic efficacy of the fenfluramine/phentermine combination in rats: additivity or synergy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

Amylin receptors mediate the anorectic action of salmon calcitonin (sCT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

7 January 2021

The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

7 January 2021

Amylin and insulin interact to reduce food intake in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

7 January 2021

Synergy between amylin and cholecystokinin for inhibition of food intake in mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

7 January 2021

Behaviorally specific inhibition of sham feeding by amylin

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

7 January 2021

The contribution of increased thermogenesis to the effect of anorectic drugs on body composition in mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

7 January 2021

Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.91

7 January 2021

Identifiers

DOI

10.1038/IJO.2008.91

1 reference

22 December 2017

1 reference

22 December 2017